Recognize the role of CD146/MCAM in the osteosarcoma progression: an in vitro study

Xing Lei, Kewei Wang, Wenbo Wang, Jin Hao, Wenguang Gu, Zhiguo Chen, Wei Wang, Kaituo Gao, Huan WangCancer 2021 · DOI

TL;DR

This study investigates the role of CD146, a cell adhesion molecule, in osteosarcoma (OS) progression. They found that CD146 promotes OS cell migration, invasion, and colony formation, and also plays a role in angiogenesis. This suggests CD146 could be a promising therapeutic target for OS, particularly in diabetic patients.

What Problem Does This Paper Address?

Osteosarcoma (OS) is a common and aggressive bone cancer with a poor prognosis, often characterized by metastasis. While CD146 has been implicated in the progression of various cancers, its specific role in OS has not been systematically studied. This paper aims to clarify CD146's contribution to OS progression, including its impact on OS cell behavior and its interaction with endothelial cells, which are crucial for tumor growth and metastasis. Additionally, the study explores how environmental factors like glucose levels might influence CD146 expression in OS, given the known link between diabetes and cancer.

Methods

The researchers employed a multi-faceted approach using both established and modified cell culture techniques:

  • Lentiviral Transfection: They engineered MG63 cells (a less aggressive OS cell line) to overexpress CD146 using lentiviral vectors. This allowed them to study the effects of CD146 upregulation.
  • Antibody Inhibition: They used a specific anti-CD146 neutralizing antibody (ab75769) to inhibit CD146 function in 143B cells (a more aggressive OS cell line).
  • Cell Migration and Invasion Assays: Standard Transwell assays were used to quantify the ability of OS cells to migrate through a membrane and invade through a Matrigel-coated membrane, assessing the role of CD146 in these metastatic processes.
  • Colony Formation Assays: Both standard colony formation and matrix colony formation assays were performed to evaluate the proliferative and tumorigenic potential of OS cells, with and without CD146 manipulation.
  • Adhesion Assays: Assays were conducted to assess the adhesion of OS cells to extracellular matrix (ECM) components (like collagen) and to human umbilical vein endothelial cells (HUVECs) (heterotypic adhesion), as well as the self-adhesion of OS cells (homotypic adhesion) using 3D spheroid assays.
  • Endothelial Cell Assays: Human umbilical vein endothelial cells (HUVECs) were cultured in conditioned media from OS cells (OS CM) to assess the impact of OS-derived factors on endothelial cell proliferation, permeability, migration, and tube formation.
  • Environmental Condition Studies: OS cells and HUVECs were cultured under various conditions, including hyperoxia (HO), low oxygen (LO), high glucose (HG), and low glucose (LG), to investigate their effect on CD146 expression.
  • Molecular Techniques: Western blotting and quantitative PCR (qPCR) were used to measure CD146 protein and mRNA expression, respectively. Immunofluorescence microscopy was employed for visualizing CD146 localization within cells.

Datasets

Not discussed in the paper. The study primarily relies on in vitro cell culture experiments using established cell lines.

Key Insights and Ideas

  • CD146 is a key driver of OS malignancy: The study provides strong evidence that CD146 actively promotes OS progression by enhancing critical metastatic behaviors like migration and invasion.
  • CD146 influences angiogenesis: Beyond its direct effects on OS cells, CD146 also impacts endothelial cells, suggesting a role in tumor vascularization, which is essential for tumor growth.
  • High glucose promotes CD146 expression: This finding is particularly significant, linking OS progression to a common comorbidity (diabetes) and suggesting a potential mechanism for increased cancer risk in diabetic patients.
  • Hypoxia has a complex effect on CD146: While hypoxia generally reduces CD146 expression, the authors speculate this might be a survival mechanism for established tumors, allowing them to adapt to harsh environments.
  • MG63 cells lack endogenous CD146: The study clarifies a discrepancy in the literature, confirming that the MG63 cell line, as used in their experiments, does not express CD146, necessitating the use of transfection to study its effects.
  • Tumor heterogeneity is not easily induced in vitro: Repeated migration of MG63 cells did not lead to increased proliferation, migration, or CD146 expression, suggesting that in vitro models may not fully capture the complex adaptive mechanisms seen in vivo.

Key Results

  • Overexpression of CD146 in MG63 cells significantly increased their colony formation, migration, and invasion capabilities.
  • Inhibition of CD146 in 143B cells reduced their proliferation, migration, and invasion.
  • CD146 was found to inhibit the adhesion of OS cells to the extracellular matrix (ECM), potentially facilitating their escape and metastasis.
  • Conditioned media from CD146-expressing OS cells (MG63-2 CM) promoted HUVEC proliferation, migration, and tube formation, while also decreasing endothelial permeability.
  • High glucose conditions significantly increased CD146 expression in both 143B and MG63-2 OS cells, whereas low oxygen conditions decreased it.
  • Co-culture of OS cells with HUVECs did not significantly alter CD146 expression in either cell type, nor did it affect heterotypic adhesion.

Limitations and Future Work

  • In vitro study: The findings are based on in vitro experiments, and further validation in in vivo models is necessary to confirm these results and their clinical relevance.
  • Complex environmental interactions: While the study explored the effects of glucose and oxygen, the interplay of various environmental factors and their combined impact on CD146 and OS progression requires further investigation.
  • Therapeutic implications: The authors suggest CD146 as a therapeutic target, particularly for diabetic OS patients. Future work should focus on developing and testing targeted therapies that inhibit CD146.
  • Mechanism of action: While the study demonstrates CD146's role, the precise molecular mechanisms by which it mediates these effects, especially its interaction with endothelial cells and its regulation by glucose, warrant deeper exploration.

Summary updated

Abstract

These findings demonstrate that CD146 promotes OS progression by mediating pro-tumoral and angiogenic effects. Thus, CD146 could be a potential therapeutic target for OS, especially for OS patients with diabetes.
BibTeX
@inproceedings{lei2021recognize,
  author = {Xing Lei and Kewei Wang and Wenbo Wang and Jin Hao and Wenguang Gu and Zhiguo Chen and Wei Wang and Kaituo Gao and Huan Wang},
  title = {{Recognize the role of CD146/MCAM in the osteosarcoma progression: an in vitro study}},
  booktitle = {Cancer},
  year = {2021},
  doi = {10.1186/s12935-021-02006-7},
}
Figure